Categories: News

Overview of the deadlines at which shares of AS Olainfarm will be excluded from the regulated market:

Overview of the deadlines at which shares of AS Olainfarm will be excluded from the regulated market:

  1. The period of the share buy-back offer began on 08.11.2021.
  2. The period of the share buy-back offer will end on 07.12.2021.
  3. Within 5 working days (until 14.12.2021.), a report on the results of the share buy-back offer will be published in the official publication Latvijas Vēstnesis and payments of shares will be made with shareholders that have accepted the share buy-back offer.
  4. Not earlier than 10 (until 29.12.2021.) and not later than 15 working days (until 06.01.2022) from the date on which the report on the results of the offer was published in the official publication Latvijas Vēstnesis AS Olainfarm will submit an application to the Nasdaq Riga stock exchange regarding the exclusion of shares from the stock exchange.
  5. Within 10 working days (until 20.01.2021.) management board of the Nasdaq Riga stock exchange will take a decision on the exclusion of the shares of AS Olainfarm from the stock exchange.

Additional information:  
Jānis Leimanis
JSC Olainfarm Member of Management Board
Phone: +371 29269424
Email: janis.leimanis@olainfarm.com

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

2 hours ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

2 hours ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

2 hours ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

2 hours ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

2 hours ago